APLT vs LLY · rev $455.0K vs P/E 39, rev $22.97B
Applied Therapeutics Inc (APLT) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Applied Therapeutics Inc (APLT) is a biotechnology company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported APLT revenue for 2024-12-31 was $455.0K. Net income was -$105.6M. APLT currently screens at market cap $14.9M.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
APLT currently screens at market cap $14.9M. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the APLT and LLY stock pages for the full models.
Not investment advice.